Abstract:Background: To evaluate the performance of fully automated deep learning (DL) algorithm for staging hepatic fibrosis and distinguishing fibrosis from normal people based on MR images with or without non-image information.Methods: 500 patients were retrospectively enrolled from two hospitals. Model DL were built using delayed phase MR images to assess fibrosis stages. In addition, different models which combined model DL with non-image information including biomarkers (APRI and FIB-4), virus status (hepatitis B and C virus tests), and MR information (manufactures and static magnetic field) were built. The AUROCs were compared between different models using Delong test, the sensitivity and specificity of both model DL and model Full (model DL combined with all non-image information) were compared with experienced radiologists and biomarkers using McNemar’s test.Findings: In the test set, the AUROC (with 95% confidence intervals) values of model Full for diagnosing fibrosis stages F0-4, F1-4, F2-4, F3-4 and F4 were 0.99 (0.94-1.00), 0.98 (0.93-0.99), 0.90 (0.83-0.95), 0.81 (0.73-0.88) and 0.84 (0.76-0.90), respectively, which outperformed model DL on diagnosing F0-4 and F1-4. Compared with the radiologists, model Full showed better specificity for fibrosis stage F0-4, better sensitivity for the other four classification tasks. While compared with biomarkers, both model DL and model Full showed significantly higher specificity in staging F3-4 and F4.Interpretation: Deep learning-based model DL and model Full using delayed phase MR images provides a promising non-invasive assessment tool for the staging liver fibrosis with a performance superior to experienced radiologists and biomarkers (APRI and FIB-4) , which may be helpful to screen out CLD patients from normal individuals, instruct which patients need treatment and prevent patients from progressing to decompensated cirrhosis by paying more attention to patients with compensated cirrhosis (F4).Funding: This work was supported by the National Natural Science Foundation of China (grant numbers 81401406) and Innovative Research Team of High-level Local Universities in Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptDeclaration of Interest: The authors declare that they have no conflict of interestEthical Approval: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening

Deep Learning Radiomics for Focal Liver Lesions Diagnosis on Long-Range Contrast-Enhanced Ultrasound and Clinical Factors

Deep Learning-Based Automated Assessment of Hepatic Fibrosis on Magnetic Resonance Images and Non-Image Data

Application of artificial intelligence techniques for non-alcoholic fatty liver disease diagnosis: A systematic review (2005-2023)

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Noninvasive Methods for Detecting Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B: A Single-Center Retrospective Study

Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis

Intelligent Diagnosis of Non-alcoholic Fatty Liver Disease Based on Multi-modal Ultrasound Features

Development of Fully Automated Models for Staging Liver Fibrosis Using Non-Contrast MRI and Artificial Intelligence: A Retrospective Multicenter Study

Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis

N-terminal Propeptide of Type 3 Collagen-Based Sequential Algorithm Can Identify High-Risk Steatohepatitis and Fibrosis in MAFLD

Simultaneous grading diagnosis of liver fibrosis, inflammation, and steatosis using multimodal quantitative ultrasound and artificial intelligence framework

Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients

Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network

Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of -Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients

Deep learning for noninvasive liver fibrosis classification: A systematic review

Machine learning models predict liver steatosis but not liver fibrosis in a prospective cohort study

Automatic Diagnosis of Significant Liver Fibrosis From Ultrasound B-Mode Images Using a Handcrafted-Feature-Assisted Deep Convolutional Neural Network

A Novel Model for Detecting Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.

Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease

Ultrasound Liver Fibrosis Diagnosis using Multi-indicator guided Deep Neural Networks